{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:12:07Z","timestamp":1768781527609,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI090599"],"award-info":[{"award-number":["R01AI090599"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000928","name":"Robert A. Welch Foundation","doi-asserted-by":"crossref","award":["I-1257"],"award-info":[{"award-number":["I-1257"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000928","name":"Robert A. Welch Foundation","doi-asserted-by":"crossref","award":["I-1422"],"award-info":[{"award-number":["I-1422"]}],"id":[{"id":"10.13039\/100000928","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.bmc.2017.07.063","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T17:31:25Z","timestamp":1501781485000},"page":"5433-5440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Synthesis and evaluation of analogs of 5\u2032-(((Z)-4-amino-2-butenyl)methylamino)-5\u2032-deoxyadenosine (MDL 73811, or AbeAdo) \u2013 An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity"],"prefix":"10.1016","volume":"25","author":[{"given":"Anthony J.","family":"Brockway","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleg A.","family":"Volkov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casey C.","family":"Cosner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S.","family":"MacMillan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Wring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas E.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Peel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jef K.","family":"De Brabander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2017.07.063_b0005","unstructured":"Lowest caseload recorded as the world prepares to defeat sleeping sickness. 16 April 2016. (Accessed June 23, 2017, at <http:\/\/www.who.int\/neglected_diseases\/news\/HAT_lowest_caseload_recorded\/en\/>.)."},{"key":"10.1016\/j.bmc.2017.07.063_b0010","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bmc.2017.07.063_b0015","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2174\/156802611795429167","article-title":"State of the art in African trypanosome drug discovery","volume":"11","author":"Jacobs","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.bmc.2017.07.063_b0020","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2017.07.063_b0025","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2017.07.063_b0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/cid\/cis886","article-title":"Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: medecins Sans Frontieres experience in the Democratic Republic of the Congo","volume":"56","author":"Alirol","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2017.07.063_b0035","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.41.9.1922","article-title":"Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D, L-alpha-difluoromethylornithine","volume":"41","author":"Iten","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.07.063_b0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pt.2015.11.001","article-title":"Tolerance to trypanosomatids: a threat, or a key for disease elimination?","volume":"32","author":"Berthier","year":"2016","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2017.07.063_b0045","doi-asserted-by":"crossref","first-page":"e1691","DOI":"10.1371\/journal.pntd.0001691","article-title":"Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal","volume":"6","author":"Jamonneau","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2017.07.063_b0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.6775372","article-title":"Polyamine metabolism: a potential therapeutic target in trypanosomes","volume":"210","author":"Bacchi","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.bmc.2017.07.063_b0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pt.2011.11.001","article-title":"Regulation and function of polyamines in African trypanosomes","volume":"28","author":"Willert","year":"2012","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.bmc.2017.07.063_b0060","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2017.07.063_b0065","doi-asserted-by":"crossref","first-page":"e720","DOI":"10.1371\/journal.pntd.0000720","article-title":"NECT is next: implementing the new drug combination therapy for Trypanosoma brucei gambiense sleeping sickness","volume":"4","author":"Yun","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.bmc.2017.07.063_b0070","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/10409238.2014.939608","article-title":"The hypusine-containing translation factor eIF5A","volume":"49","author":"Dever","year":"2014","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.bmc.2017.07.063_b0075","doi-asserted-by":"crossref","first-page":"5232","DOI":"10.1074\/jbc.M112.442475","article-title":"Trypanosoma brucei S-adenosylmethionine decarboxylase N terminus is essential for allosteric activation by the regulatory subunit prozyme","volume":"288","author":"Velez","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2017.07.063_b0080","doi-asserted-by":"crossref","first-page":"8275","DOI":"10.1073\/pnas.0701111104","article-title":"Allosteric regulation of an essential trypanosome polyamine biosynthetic enzyme by a catalytically dead homolog","volume":"104","author":"Willert","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bmc.2017.07.063_b0085","doi-asserted-by":"crossref","first-page":"9111","DOI":"10.1021\/ja00207a024","article-title":"5'-{[(Z)-4-Amino-2-butenyl]methylamino}-5'-deoxyadenosine: a potent enzyme-activated irreversible inhibitor of S-adenosyl-L-methionine decarboxylase from Escherichia coli","volume":"111","author":"Casara","year":"1989","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2017.07.063_b0090","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1128\/AAC.34.8.1485","article-title":"Cure of Trypanosoma brucei brucei and Trypanosoma brucei rhodesiense infections in mice with an irreversible inhibitor of S-adenosylmethionine decarboxylase","volume":"34","author":"Bitonti","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.07.063_b0095","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/0006-2952(90)90446-R","article-title":"Irreversible inhibition of rat S-adenosylmethionine decarboxylase by 5\u2032-{[(Z)-4-amino-2-butenyl]methylamino}-5\u2032-deoxyadenosine","volume":"40","author":"Danzin","year":"1990","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2017.07.063_b0100","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1021\/bi00144a027","volume":"31","author":"Shantz","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2017.07.063_b0105","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1128\/AAC.36.12.2736","article-title":"Cure of murine Trypanosoma brucei rhodesiense infections with an S-adenosylmethionine decarboxylase inhibitor","volume":"36","author":"Bacchi","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.07.063_b0110","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1128\/AAC.01674-08","article-title":"Novel S-adenosylmethionine decarboxylase inhibitors for the treatment of human African trypanosomiasis","volume":"53","author":"Barker","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.07.063_b0115","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1055\/s-0035-1561608","article-title":"Improved Synthesis of MDL 73811 \u2013 a Potent AdoMetDC Inhibitor and Anti-Trypanosomal Compound","volume":"48","author":"Brockway","year":"2016","journal-title":"Synthesis"},{"key":"10.1016\/j.bmc.2017.07.063_b0120","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1128\/AAC.00076-09","article-title":"Trypanocidal activity of 8-methyl-5'-{[(Z)-4-aminobut-2-enyl]-(methylamino)}adenosine (Genz-644131), an adenosylmethionine decarboxylase inhibitor","volume":"53","author":"Bacchi","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2017.07.063_b0125","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1021\/jm0201621","article-title":"Synthesis and Evaluation of Analogues of 5\u2018-([(Z)-4-Amino-2-butenyl]methylamino)-5\u2018-deoxyadenosine as Inhibitors of Tumor Cell Growth, Trypanosomal Growth, and HIV-1 Infectivity\u2020","volume":"45","author":"Marasco","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2017.07.063_b0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acsinfecdis.7b00022","article-title":"Identification of Trypanosoma brucei AdoMetDC inhibitors using a high-throughput mass spectrometry-based assay","volume":"3","author":"Volkov","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2017.07.063_b0135","unstructured":"See Supporting Information for full details."},{"key":"10.1016\/j.bmc.2017.07.063_b0140","doi-asserted-by":"crossref","first-page":"9158","DOI":"10.1021\/ja00781a029","article-title":"Stereopopulation control. I. Rate enhancement in the lactonizations of o-hydroxyhydrocinnamic acids","volume":"94","author":"Milstien","year":"1972","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2017.07.063_b0145","doi-asserted-by":"crossref","first-page":"9175","DOI":"10.1021\/ja00781a031","article-title":"Stereopopulation control. III. Facilitation of intramolecular conjugate addition of the carboxyl group","volume":"94","author":"Borchardt","year":"1972","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2017.07.063_b0150","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1039\/c2sc20536j","article-title":"Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology","volume":"3","author":"Levine","year":"2012","journal-title":"Chem Sci"},{"key":"10.1016\/j.bmc.2017.07.063_b0155","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/mmi.13083","article-title":"GMP synthase is essential for viability and infectivity of Trypanosoma brucei despite a redundant purine salvage pathway","volume":"97","author":"Li","year":"2015","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.bmc.2017.07.063_b0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1747-0285.2006.00389.x","article-title":"Discovery of trypanocidal compounds by whole cell HTS of Trypanosoma brucei","volume":"67","author":"Mackey","year":"2006","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.bmc.2017.07.063_b0165","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0022-3565(24)29270-3","article-title":"Rational use of in vitro P-glycoprotein assays in drug discovery","volume":"299","author":"Polli","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bmc.2017.07.063_b0170","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/jps.20166","article-title":"In vitro absorption and secretory quotients: practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidates","volume":"93","author":"Thiel-Demby","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.bmc.2017.07.063_b0175","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1023\/A:1025001131513","article-title":"Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium","volume":"20","author":"Troutman","year":"2003","journal-title":"Pharm Res"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617313019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089617313019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:52:03Z","timestamp":1760835123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089617313019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":35,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0968089617313019"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2017.07.063","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of analogs of 5\u2032-(((Z)-4-amino-2-butenyl)methylamino)-5\u2032-deoxyadenosine (MDL 73811, or AbeAdo) \u2013 An inhibitor of S-adenosylmethionine decarboxylase with antitrypanosomal activity","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2017.07.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}